z-logo
open-access-imgOpen Access
Dostarlimab “A Miracle Drug Against Cancer”: Current Knowledge and On-going Clinical Trials
Author(s) -
Mohammed Asadullah Jahangir
Publication year - 2022
Publication title -
international journal of biomedical investigation
Language(s) - English
Resource type - Journals
ISSN - 2581-4745
DOI - 10.31531/2581-4745.1000140
Subject(s) - cancer , immunotherapy , medicine , immune system , chinese hamster ovary cell , monoclonal antibody , clinical trial , antibody , immune checkpoint , cancer cell , oncology , immunology , cancer research , receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here